As of 3:59pm ET
| +1.32 / +5.40%|
The 1 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +55.16% increase from the last price of 25.78.
The current consensus among 2 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.